What the Latest Findings Say About Dexamethasone

A study published in the New England Journal of Medicine reports that among people hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day risk of death for people who were receiving either invasive mechanical ventilation or oxygen alone at randomization. However, the drug did not show a benefit for people receiving no respiratory support.

The study observed around 2,100 people hospitalized for Covid-19. A portion of the group was randomly assigned to receive 10 days’ worth of dexamethasone combined with their standard care…




A blog from Medium for Covid-19 news, advice, and commentary.

Recommended from Medium

We May Never Know How Many People Have Coronavirus

Changed Conditions?!

When Doctors Spread Misinformation, Can Anything Be Done?

A man asks his doctor a question while pointing at his diagnosis on the tablet.

The New Covid-19 Variant Exposes the World’s Hypocrisy

The Latest: Does Covid-19 hide in the body?

Would You Volunteer to Be Exposed to the Coronavirus for the Sake of Science?

An Open Letter to the Media of Saskatchewan

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Alexandra Sifferlin

Alexandra Sifferlin

Health and science journalist. Former editor of Medium’s Covid-19 Blog and deputy editor at Elemental. TIME Magazine writer before that

More from Medium

We Are Looking At Student Loan Forgiveness All Wrong

Plum Viewing

What Does Energy Independence Actually Mean?

How the Ever Forward Is Like Her Sister